New combo therapy shows promise for tough breast cancer
Disease control
ENROLLING_BY_INVITATION
This study tests a combination of two drugs (sacituzumab govitecan and bevacizumab) for people with metastatic triple-negative breast cancer that has already been treated. The goal is to see if the combo can shrink tumors or slow the disease. About 60 adults will take part across…
Phase: PHASE2 • Sponsor: YING FAN • Aim: Disease control
Last updated May 17, 2026 06:49 UTC